Zaloguj się

Yuan-Feng Gong

Department of Hepatobiliary Surgery,
Affiliated Cancer Hospital,
Department of Hepatobiliary Surgery, Affiliated Cancer Hospital

Guangzhou Medical University

BIOGRAPHY

Yuan-Feng Gong has not added Biography.

If you are Yuan-Feng Gong and would like to personalize this page please email our Author Liaison for assistance.

PUBLICATIONS

The complete mitochondrial genome of malbrouck monkey, Chlorocebus cynosuros (Chlorocebus, Cercopithecinae).

Mitochondrial DNA. Part A, DNA mapping, sequencing, and analysis , 2016 | Pubmed ID: 25185937

The complete mitochondrial genome of Japanese macaque, Macaca fuscata fuscata (Macaca, Cercopithecinae).

Mitochondrial DNA. Part A, DNA mapping, sequencing, and analysis May, 2016 | Pubmed ID: 25242185

Laparoscopic Hyperthermic Intraperitoneal Perfusion Chemotherapy for Patients with Malignant Ascites Secondary to Unresectable Gastric Cancer.

Journal of laparoendoscopic & advanced surgical techniques. Part A Jan, 2016 | Pubmed ID: 26779722

Port-Site Metastases and Chimney Effect of B-Ultrasound-Guided and Laparoscopically-Assisted Hyperthermic Intraperitoneal Perfusion Chemotherapy.

Yonsei medical journal May, 2017 | Pubmed ID: 28332353

Optimized construction of MUC1-VNTR DNA vaccine and its anti-pancreatic cancer efficacy.

Oncology letters Apr, 2017 | Pubmed ID: 28454381

Mild hyperthermia enhances sensitivity of gastric cancer cells to chemotherapy through reactive oxygen species-induced autophagic death.

Tumour biology : the journal of the International Society for Oncodevelopmental Biology and Medicine Jun, 2017 | Pubmed ID: 28639902

Long noncoding RNA LINC00673 epigenetically suppresses KLF4 by interacting with EZH2 and DNMT1 in gastric cancer.

Oncotarget Nov, 2017 | Pubmed ID: 29221147

Development of an oncogenic dedifferentiation SOX signature with prognostic significance in hepatocellular carcinoma.

BMC cancer Aug, 2019 | Pubmed ID: 31462277

Thermo-chemotherapy inhibits the proliferation and metastasis of gastric cancer cells via suppression of EIF5A2 expression.

OncoTargets and therapy , 2019 | Pubmed ID: 31496731

LncRNA AC093818.1 accelerates gastric cancer metastasis by epigenetically promoting PDK1 expression.

Cell death & disease Jan, 2020 | Pubmed ID: 31988283

Laparoscopic Hyperthermic Intraperitoneal Perfusion Chemotherapy for Patients With Malignant Ascites Secondary to Unresectable Gastric Cancer.

Surgical laparoscopy, endoscopy & percutaneous techniques Feb, 2020 | Pubmed ID: 32004214

A hepatocyte differentiation model reveals two subtypes of liver cancer with different oncofetal properties and therapeutic targets.

Proceedings of the National Academy of Sciences of the United States of America 03, 2020 | Pubmed ID: 32123069

Identification of prognostic claudins signature in hepatocellular carcinoma from a hepatocyte differentiation model.

Hepatology international Jul, 2020 | Pubmed ID: 32304089

Pancreatic neuroendocrine tumors: A review of serum biomarkers, staging, and management.

World journal of gastroenterology May, 2020 | Pubmed ID: 32476795

Targeting tumor lineage plasticity in hepatocellular carcinoma using an anti-CLDN6 antibody-drug conjugate.

Science translational medicine 02, 2021 | Pubmed ID: 33536280

Knockdown of lncRNA ZNRD1-AS1 suppresses gastric cancer cell proliferation and metastasis by targeting the miR-9-5p/HSP90AA1 axis.

Aging Jul, 2021 | Pubmed ID: 34226297

Should people with chronic liver diseases be vaccinated against COVID-19?

World journal of clinical cases Sep, 2021 | Pubmed ID: 34621852

Growth differentiation factor 1-induced tumour plasticity provides a therapeutic window for immunotherapy in hepatocellular carcinoma.

Nature communications 12, 2021 | Pubmed ID: 34880251

Single-cell transcriptome sequencing reveals potential novel combination of biomarkers for antibody-based cancer therapeutics in hepatocellular carcinoma.

Frontiers in genetics , 2022 | Pubmed ID: 36186483

INSTITUTIONS

Guangzhou Medical University

JOVE ARTICLES

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

Cheng-Yang Zhang^*,1,2,

Xiao-Feng Zhang^*,3,

Jun Yuan^*,1,2,

Yuan-Feng Gong⁴,

Hui Tang⁴,

Wan-Yu Guo^1,2,

Tong-Yan Li^1,2,

Cai-Wen Li^1,2,

Yun-Qiang Tang⁴,

Ning-Fang Ma^1,2,

Ming Liu^1,2

¹, Affiliated Cancer Hospital and Institute of Guangzhou Medical University,

²Guangzhou Municipal and Guangdong Provincial Key Laboratory of Protein Modification and Degradation, Center for Cancer Research and Translational Medicine, School of Basic Medical Sciences, Guangzhou Medical University,

³Department of Pediatric Surgery, Guangzhou Institute of Pediatrics, Guangzhou Women and Children’s Medical Center, Guangzhou Medical University,

⁴Department of Hepatobiliary Surgery, Affiliated Cancer Hospital, Guangzhou Medical University

Cancer Research

Prywatność

Warunki Korzystania

Zasady

Skontaktuj Się z Nami

Poleć Bibliotece

BIULETYNY JoVE

Badania

JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archiwum

Edukacja

JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Centrum Zasobów Akademickich
Strona Wydziału

Autorzy

Przegląd
Proces Publikacji
Rada Redakcyjna
Zakres i Zasady
Recenzja ekspercka
FAQ
Prześlij

Bibliotekarze

Przegląd
Referencje
Subskrypcje
Dostęp
Zasoby
Biblioteczna Rada Doradcza
FAQ

O JoVE

Przegląd
Kierownictwo
Blog
JoVE Help Center
JoVE Sitemap

Yuan-Feng Gong

.css-o250i3{font-size:18px;font-family:Open Sans,sans-serif;line-height:21.6px;}Department of Hepatobiliary Surgery,Affiliated Cancer Hospital,Department of Hepatobiliary Surgery, Affiliated Cancer Hospital

Guangzhou Medical University

Development and Optimization of A Human Hepatocellular Carcinoma Patient-Derived Organoid Model for Potential Target Identification and Drug Discovery

Department of Hepatobiliary Surgery,
Affiliated Cancer Hospital,
Department of Hepatobiliary Surgery, Affiliated Cancer Hospital